Neurogene
NGNE
39 hedge funds and large institutions have $171M invested in Neurogene in 2015 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 11 increasing their positions, 5 reducing their positions, and 7 closing their positions.
120% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 5
86% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 7
18% more funds holding
Funds holding: 33 → 39 (+6)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
6% less capital invested
Capital invested by funds: $183M → $171M (-$11.1M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$2.68M |
| 2 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$2.44M |
| 3 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$1.16M |
| 4 |
Morgan Stanley
New York
|
+$829K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$824K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
-$7.24M |
| 2 |
First Manhattan
New York
|
-$2.81M |
| 3 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$1.41M |
| 4 |
HCM
Highbridge Capital Management
New York
|
-$399K |
| 5 |
Millennium Management
New York
|
-$327K |
NGNE Hedge Fund Activity: Q4 2015 in Review
39 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Neurogene (NGNE) for Q4 2015, worth a combined $171M — down 6.1% from $183M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new NGNE positions and 7 closed out — a net gain of 6 holders — while 11 added to existing stakes and 5 trimmed.
The largest buyer was BlackRock Fund Advisors, opening a new position worth an estimated $2.68M. The largest seller was Redmile Group, exiting entirely with an estimated $7.24M sold.
- 39 institutional investors held Neurogene (NGNE) as of Q4 2015, up from 33 in Q3 2015.
- Funds reported $171M of Neurogene stock for Q4 2015, down 6.1% quarter-over-quarter.
- 13 funds opened new Neurogene positions in Q4 2015 and 7 closed out, a net change of +6 holders.
- The largest Neurogene buyer in Q4 2015 was BlackRock Fund Advisors, an estimated $2.68M added.
- The largest Neurogene seller in Q4 2015 was Redmile Group, an estimated $7.24M sold.
Based on aggregated 13F filings for Q4 2015.